Can paroxetine be used to treat bulimia nervosa in an adult, and what are the recommended dosing and monitoring guidelines?

Paroxetine is NOT Recommended for Bulimia Nervosa

Fluoxetine at 60 mg daily, not paroxetine, is the recommended serotonin reuptake inhibitor for treating bulimia nervosa in adults. The 2023 American Psychiatric Association guidelines specifically recommend fluoxetine as the SSRI of choice for this indication 1.

Why Fluoxetine, Not Paroxetine?

The APA guidelines explicitly state that adults with bulimia nervosa should receive eating disorder-focused cognitive-behavioral therapy combined with "a serotonin reuptake inhibitor (e.g., 60 mg fluoxetine daily)" 1. This recommendation carries a 1C grade, indicating confidence that benefits outweigh harms.

Critical distinction: While paroxetine is FDA-approved for multiple psychiatric conditions (major depression, OCD, panic disorder, social anxiety disorder, GAD, and PTSD) 2, it has no FDA approval or guideline support for bulimia nervosa. The FDA label for paroxetine makes no mention of eating disorders as an indication 2.

The Evidence Base

For Fluoxetine (The Correct Choice):

• Multiple controlled trials demonstrate efficacy at the specific dose of 60 mg daily
• This is substantially higher than the typical antidepressant dose (20 mg)
• The higher dose appears necessary for anti-bulimic effects

For Paroxetine (Lacks Support):

Research evidence shows antidepressants as a class can reduce bulimic symptoms 3, but:

• No specific trials establish paroxetine's efficacy in bulimia nervosa
• Guidelines from multiple organizations (APA, WFSBP, NICE) do not recommend paroxetine specifically 4, 5
• The general statement that "antidepressants are commonly used" 6 does not justify choosing paroxetine over the evidence-based fluoxetine

Treatment Algorithm for Bulimia Nervosa

First-line approach:

1. Initiate eating disorder-focused CBT immediately
2. Add fluoxetine 60 mg daily either:
   • At treatment initiation, OR
   • If minimal/no response to psychotherapy alone by 6 weeks 1

If fluoxetine is contraindicated or not tolerated:

• Other SSRIs may be considered based on class effect data 3
• However, this represents off-label use without the specific evidence base that fluoxetine possesses

Monitoring Requirements

Before initiating any SSRI for bulimia nervosa, obtain 1:

• ECG - mandatory in patients with severe purging behavior (risk of QTc prolongation)
• Complete blood count
• Comprehensive metabolic panel including electrolytes (hypokalemia from purging), liver enzymes, renal function
• Vital signs including orthostatic measurements
• Weight and BMI

Monitor for electrolyte disturbances particularly if purging continues, as this affects cardiac safety with any psychotropic medication.

Common Pitfall to Avoid

Do not assume all SSRIs are interchangeable for bulimia nervosa. While they share a mechanism of action, only fluoxetine at 60 mg daily has the evidence base and guideline support. The dose matters critically - standard antidepressant doses (20 mg) are insufficient for treating bulimic symptoms.

Adolescents and Emerging Adults

For younger patients with involved caregivers, eating disorder-focused family-based treatment is suggested over medication as first-line therapy 1.